ECIRS versus PCNL for renal stone management. A meta-analysis of 3 studies with over 300 patients found that ECIRS had a shorter mean operative time and higher stone-free rate compared to PCNL, but similar length of hospital stay. A randomized controlled trial assessed 67 patients and found ECIRS had a shorter operative time and higher stone-free rate. Risk of bias was low. The analysis concluded ECIRS is more efficacious than PCNL for renal stones.
Dr Ho Siew Hong shared his experience on how to perform the ideal puncture for PCNL in a lecture to Asian urologists during the Advanced Urology Course 2008 in Singapore
What is New In Minimally Invasive Surgery for UrologySiewhong Ho
Dr Ho Siew Hong gave a series of Continous Medical Education lectures to doctors of Gleneagles, Mount Elizabeth and East Shore Hospitals on the latest in Urology surgery
Retrograde Intrarenal Ureteroscopic Surgery (RIRS)Urovideo.org
Gerhard J. Fuchs, M.D., Dr. med., F.A.C.S.
Professor of Urology, UCLA School of Medicine
Vice Chair, Cedars Sinai Department of Surgery
Medallion Chair in Minimally Invasive Urology
Cedars-Sinai Medical Center
Los Angeles, USA
Ureteroscopy has gained a place as a primary treatment modality for many urologic applications including stone diseases, ureteropelvic junction obstruction, and upper urinary tract transitional cell carcinoma with high success rates
Dr Ho Siew Hong shared his experience on how to perform the ideal puncture for PCNL in a lecture to Asian urologists during the Advanced Urology Course 2008 in Singapore
What is New In Minimally Invasive Surgery for UrologySiewhong Ho
Dr Ho Siew Hong gave a series of Continous Medical Education lectures to doctors of Gleneagles, Mount Elizabeth and East Shore Hospitals on the latest in Urology surgery
Retrograde Intrarenal Ureteroscopic Surgery (RIRS)Urovideo.org
Gerhard J. Fuchs, M.D., Dr. med., F.A.C.S.
Professor of Urology, UCLA School of Medicine
Vice Chair, Cedars Sinai Department of Surgery
Medallion Chair in Minimally Invasive Urology
Cedars-Sinai Medical Center
Los Angeles, USA
Ureteroscopy has gained a place as a primary treatment modality for many urologic applications including stone diseases, ureteropelvic junction obstruction, and upper urinary tract transitional cell carcinoma with high success rates
HoLEP: the gold standard for the surgical management of BPH in the 21st CenturyDr. Manjul Maurya
HoLEP is at least as effective as other surgical therapies, including TURP, OP and other laser modalities, with fewer complications, shorter hospital stays, and decreased catheter time. These benefits make HoLEP the procedure of choice for men seeking surgical relief for BPH related LUTS and the gold standard for the 21st Century.
HoLEP: the gold standard for the surgical management of BPH in the 21st CenturyDr. Manjul Maurya
HoLEP is at least as effective as other surgical therapies, including TURP, OP and other laser modalities, with fewer complications, shorter hospital stays, and decreased catheter time. These benefits make HoLEP the procedure of choice for men seeking surgical relief for BPH related LUTS and the gold standard for the 21st Century.
Long-Term Outcomes of Endoscopic Treatment for Bile Duct Stones in Patients A...JohnJulie1
There are limited data regarding the safety and efficacy of complete stone removal for the treatment of bile duct stones in elderly patients. Hence, this study evaluated the long-term outcomes of complete stone removal in elderly patients.
Long-Term Outcomes of Endoscopic Treatment for Bile Duct Stones in Patients A...JapaneseJournalofGas
There are limited data regarding the safety and efficacy of complete stone removal for the treatment of bile duct stones in elderly patients. Hence, this study evaluated the long-term outcomes of complete stone removal in elderly patients.
Non-surgical adjunctive interventions for accelerating tooth movement in pati...Dr. Yahya Alogaibi
Non-surgical adjunctive interventions for accelerating tooth movement in patients undergoing fixed orthodontic treatment by Ahmed El-Angbawi, Grant T McIntyre, Padhraig S Fleming, David R Bearn ppt
Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction - clinical outcome and quality of life: a bi-center prospective study
Urology Journal Club
Surgical adjunctive procedures for accelerating orthodontic treatment by Padh...Dr. Yahya Alogaibi
Surgical adjunctive procedures for accelerating orthodontic treatment by Padhraig S Fleming, Zbys Fedorowicz, Ama Johal, Ahmed El-Angbawi, Nikolaos Pandis ppt
Similar to Erirs vs pcnl uro fair2019 eko indra (20)
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
1. Endoscopic Combined Intrarenal Surgery versus
Percutaneous Nephrolithotomy for Renal
Stones Management: A Meta-analysis
Eko Indra Pradono, MD
Faculty of Medicine, Universitas Indonesia / H. Adam Malik Hospital, Medan, Indonesia
Presented at :
4-6th April Grand Hyatt, Singapore
2. REFERENCES
INTRODUCTION
• ECIRS
• Novel way to approach renal cavities antero-retrogradely to remove renal stones
combining PCNL and fURS
• Useful in managing patient with large stones, special cases (regardless of age and body
habitus)
• Provides benefits minimizing radiation exposure & risk of haemorrhage
• PCNL
• Gold standard for renal stones management
• Unfortunately the residual remains high
INTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION
AIM OF THE STUDY
Compare efficacy and safety of ECIRS and PCNL in renal stones management regarding mean operative
time, final stone free rate, and length of stay
3. REFERENCES
METHODS
• Conducted according to PRISMA guidelines
• PICO
P patients with renal stones
I endoscopic combined intrarenal surgery (ECIRS)
C percutaneous nephrolithotomy (PCNL)
O mean operative time, final stone free-rate, length of hospital stay
• A systematic literature search was conducted in October 2018 using Medline
(PubMed), Google Scholar, Science Direct, and Cochrane.
INTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION
4. REFERENCES
• Database, search strategy, and number of articles retrieved
INTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION
Database Search strategy Hits
MEDLINE
(PubMed)
(((endoscopic combined intrarenal surgery [All Fields]) OR ECIRS [All Fields]))) AND (((PCN [All Fields])) OR PCNL [All Fields])) OR
percutaneous nephrolithotomy [All Fields])) AND (stone-free rate [All Fields]) AND (mean operative time [All Fields]) AND (length of
hospital stay [All Fields])
9
Google Scholar
"endoscopic combined intrarenal surgery"; "percutaneous nephrolithotomy"; "stone-free rate"; "operative time"'; "length of
hospital stay"
9
Science Direct endoscopic combined intrarenal surgery; percutaneous nephrolithotomy; stone-free rate; operative time; length of hospital stay 4
Cochrane
((endoscopic combined intrarenal surgery [All text]) AND (percutaneous nephrolithotomy [All text]) AND (stone-free rate [All text])
AND (operative time [All text]) AND (length of hospital stay [All text]))
1
• Study selection
• Full-text potential article was independently assessed by 3 reviewers (EIP, FP, DD).
• Duplication was also screened manually abstract examination based on predetermined inclusion
and exclusion criteria.
• Exclusion criteria:
• Only discussed about one arm; review or meta-analysis; duplicated data; comments, editorials, letters, case reports,
congress reports; animal experiments; and non-English articles.
5. REFERENCESINTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION
• Data extraction and quality assessment
• Cross-reference was conducted to ensure the studies which were not found in computerized search.
• Randomized clinical trial (RCT) Modified Jadad score, cohort studies Newcastle-Ottawa Scale
(NOS)
• Criteria for studies
• Type of source outcomes: mean operative time, final stone-free rate, length of hospital stay
• Data collection and statistical analysis
• Selected studies were appraised based on the Oxford Center of Evidence-based Medicine
Worksheet for therapy and analyzed by Review Manager 5.3.
• Mean operative time and length of hospital stay were estimated using MD & 95% CI
• Stone-free rate was estimated using OR and 95% CI.
• P-value <0.005 was considered statistically significant.
• Heterogeneity was evaluated using Cochrane Q statistic & I2 statistic.
6. REFERENCES
RESULTS
• Literature search
• Total 23 publications at initial; 10
studies were excluded due to
duplication.
• Moreover, 7 were excluded during title
and abstract screening.
• 6 studies underwent full-text appraisal,
but only 3 studies were considered for
further qualitative and quantitative
analysis.
INTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION
Cochrane
1
PubMed
9
Google
Scholar
9
Science Direct
4
Filtering doubles
13
Screening title abstract*
6
Full text and abstract are assessed for availability and eligibility*
3 studies included in qualitative synthesis
Percutaneous
nephrolithotomy
OR PCN OR PCNL
Stone-
free rate
OR SFR
Length of
hospital
stay
A
N
D
Endoscopic
combined intrarenal
surgery OR ECIRS
Exclusion ciriteria:
- Children patients
- Only discuss
ECIRS or PCNL
Exclusion criteria:
- Non-English
studies
- Descriptive studies
- Non comparative
studies
Search period: October 2018
*All decisions were made by discussions of 3 reviewers
3 studies included in quantitative synthesis
IdentificationScreeningEligibilityIncluded
A
N
D
Operative
time OR
operative
duration
A
N
D
A
N
D
7. REFERENCESINTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION
• Study characteristics
• 3 studies were further analyzed.
• 1 study was prospective RCT (assessed using modified Jadad and scored 8 over 8), 2 studies
were prospective cohort (assessed with NOS)
Author(s) Year Study design
Number of patients Mean operative time Stone-free rate Length of hospital stay (days)
ECIRS PCNL ECIRS PCNL ECIRS PCNL ECIRS PCNL
Hamamoto
et al
2014 Retrospective
cohort
60 82 120.5 ± 6.7 134.1 ± 7.8 86.7% 61.1% 7.0 ± 0.6 12.9 ± 1.4
Zelvys et al 2014 Cohort
prospective
22 182 98.54 ± 26 85.27 ± 22.5 94.2% 90.3% 5.4 ± 1.7 5.2 ± 0.9
Wen at al 2016 Randomized
controlled
trial
33 34 105.33 ± 30.28 83.58 ± 24.37 96.97%
(32/33)
91.18%
(31/34)
9.66 ± 2.31 10.12 ± 2.11
8. REFERENCESINTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION
• Risk of bias summary
• Most of aspects are good in the risk of bias assessment.
• The study conducted by Wen et al recruited 67 patients and they were randomly assigned to two
groups: ECIRS and PCNL group.
• This study did not only select RCT study because there were only few studies comparing ECIRS and
PCNL in the terms of mean operative time, stone-free rate, and length of hospital stay.
11. REFERENCES
CONCLUSION
ECIRS is more efficacious compared to PCNL in renal stones
management evaluated from mean operative time, stone-free rate, and
length of hospital stay.
INTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION
12. REFERENCES
1. Ping H, Zhang JH, Wang MS, Xing NZ. Endoscopic combined intrarenal surgery for the treatment of postpercutaneous nephrolithotomy residual
stones. CMJ. 2016;129(23):2885-7.
2. Manikandan R, Mittal JK, Dorairajan LN, Mishra AK, Sreerag KS, et al. Endoscopic combined intrarenal surgery for simultaneous renal and ureteric
stones: a retrospective study. J Endourol. doi: 10.1089/end.2016.0329.
3. Hamamoto S, Yasui T, Okada A, Taguchi K, Kawai N, et al. Endoscopic combined intrarenal surgery for large calculi: simultaneous use of flexible
ureteroscopy and mini-percutaneous nephrolithotomy overcomes the disadvantageous of percutaneous nephrolithotomy monotherapy. J
Endourol. 2014;28(1):23-33.
4. Zelvys A, Cekauskas A, Jankevicius F. Role of combined intrarenal surgery (ECIRS) in management of large/complex kidney stones. Eur Urol Suppl
2014; 13(2): e1192.
5. Wen J, Xu G, Du C, Wang B. Minimally invasive percutaneous nephrolithotomy versus endoscopic combined intrarenal surgery with flexible
ureteroscope for partial staghorn calculi: a randomised controlled trial. Int J Surg. 2016;28:22-27.
6. De La Rosette JJ, Tsakiris P, Ferrandino MN, et al. Beyond prone position in percutaneous nephrolithotomy: a comprehensive review. Eur Rol.
2008;54:1262-9.
7. Yamashita S, Kohjimoto Y, Iba A, Kikkawa K, Hara I. Stone size is a predictor for residual stone and multiple procedures of endoscopic combined
intrarenal surgery. Scand J Urol Nephrol. 2017;51(2):159-164.
8. Ritter M, Krombach P, Michel MS. Percutaneous stone removal. Eur Urol Suppl. 2011;10:433-9.
INTRODUCTION METHODS RESULTS DISCUSSION CONCLUSION REFERENCES